https://www.idival.org/wp-content/uploads/2022/05/cab-presentacion.jpg

The Dermatology Departments of Valdecilla, Sierrallana and Tres Mares are studying an alternative treatment for androgenetic alopecia

13 de May de 2024

Microinjections with the drug dustaterida improve hair density and diameter, have no adverse effects and reduce side effects compared to current oral treatment. A research team from the Dermatology Department of the Marqués de Valdecilla University Hospital (HUMV), the Sierrallana Regional Hospital and Tres Mares Hospital are studying a new treatment for patients with hair […]

Read more →

IDIVAL organizes a round table focused on the use of artificial intelligence in the health care environment

10 de May de 2024

The event will take place on May 21 at IDIVAL’s facilities The Marqués de Valdecilla Health Research Institute (IDIVAL) is organizing a round table discussion entitled “Artificial intelligence: how can we use it in the healthcare environment” on May 21. The initiative will take place in person at the IDIVAL headquarters at 13:30h and will […]

Read more →

IDIVAL evaluates the activity of its research groups in its External Scientific Council

6 de May de 2024

This advisory body meets regularly and ensures the scientific quality of the institute. The members of the External Scientific Council of the Marqués de Valdecilla Health Research Institute (IDIVAL) met last week at IDIVAL and online in order to evaluate the activity of some research groups of the center, as well as to monitor the […]

Read more →

Single-parent families have lower incomes, poorer physical health or weaker supportive relationships according to a study by IDIVAL’s Health Economics Group

30 de April de 2024

The conclusions obtained in the research could help design policies to address the difficulties of this type of families. A recent study published in the international Journal of Family and Economic Issues by the Health Economics Group of the Marqués de Valdecilla Health Research Institute (IDIVAL) explored economic circumstances, lifestyle factors (obesity, smoking and alcohol) […]

Read more →

Cantabria joins the European FAITHFUL project for early detection of heart failure with artificial intelligence

23 de April de 2024

1.7 million, the project will run until the end of 2025 and will involve leading international institutions in the sector.  The FAITHFUL,  innovation project consortium, led by the Spanish startup Idoven, thanks to the support of EIT Health, has just launched the development of a technological solution that aims to prevent 4 out of 10 […]

Read more →

Santander will host the first international symposium on rare liver diseases

3 de April de 2024

IDIVAL researcher Javier Crespo is coordinating the congress, which will take place on 11th and 12th April The 1st International Symposium on Rare Liver Diseases 2024 will bring together leading national and international experts in the field of rare liver diseases, with the aim of sharing knowledge, scientific advances and clinical experiences relevant to the […]

Read more →

IDIVAL researcher Lourdes Valdivia, winner of the Juan María Parés Research Awards for her innovative thesis on nanomedicine

21 de March de 2024

The work focuses on the transport of drugs through lipid nanosystems. The University of Cantabria has announced the winners of the ‘Juan María Parés Research Awards’ in the doctoral thesis category, highlighting the work of Lourdes Valdivia Fernández in the area of Health Sciences. Valdivia’s thesis was supervised by researchers Mónica López Fanarraga and Rafael […]

Read more →

IDIVAL and the Optics Group of the University of Cantabria collaborate to advance in glioblastoma surgery through the use of light

The work will allow the development of an optical sensor for the precise identification of tumour margins. Researchers from the Cell Signalling and Therapeutic Targets in Cancer Group of the Valdecilla Research Institute (IDIVAL) and the Optics Group of the University of Cantabria (UC) are collaborating in the development of an optical sensor to aid […]

Read more →

IDIVAL researcher Julio Pascual receives the Juan María Parés 2023 Research Award from the UC Social Council

11 de March de 2024

The scientist considers that “this recognition should serve as an incentive to promote, even more, the interest in research among the professionals of the Marqués de Valdecilla University Hospital”. Julio Pascual Gómez, head of the ‘Clinical and Genetics of Headaches’ group at the Valdecilla Research Institute (IDIVAL) and head of the Neurology Service at the […]

Read more →

The UC-IDIVAL Photonics Engineering group will develop a technological platform focused on healthy aging

7 de March de 2024

The initiative is formed by a consortium between IDIVAL, the Ámbar Group and the University of Cantabria The scientific director of the Marqués de Valdecilla Health Research Institute (IDIVAL), Marcos López-Hoyos; the rector of the University of Cantabria (UC), Ángel Pazos; and the president of Grupo Ámbar, Pablo Gómez, presented yesterday, together with the researcher […]

Read more →